Why gene-therapy drugs are so expensive
By N.L.,
The Economist
| 08. 03. 2016
Untitled Document
On August 3rd the British pharmaceutical company GSK said that it would charge €594,000 ($665,000) for a gene-therapy cure for ADA-SCID—a severe immune disorder that is usually fatal in the first few years of life. A child born with ADA-SCID is unable to fight off everyday infections; Strimvelis has cured this in each of the 18 children it has been tested on over 15 years. Gene therapies work by delivering correct versions of DNA, usually using a virus as a vector. Once DNA is inside the cell, it produces the protein that was missing and the fault is fixed. Scientists have been trying to develop gene therapies for decades. Early work hit the buffers due to a series of unexpected cancers, the death of a young man during a trial, and some disappointing results.
Much progress has been made since then and according to analysts at Datamonitor Healthcare the number of gene therapies in development has doubled since 2012. Last week, America’s Food and Drug Administration (FDA) handed out “breakthrough” designations—intended to hasten the approval of important new... see more
Related Articles
By Manuel Ansede, El País | 01.15.2023
The gene editing techniques that have revolutionized medicine since 2016 could also be used to treat common heart diseases, the number one cause of death in humans, according to a study published recently by one of the world’s leading scientists, ...
By David Jensen, The California Stem Cell Report | 01.11.2023
Two prestigious campuses of the University of California are eyeing the creation of an entity that would cover the multimillion-dollar price tags of genetic therapies for the life-threatening bubble baby disease.
Also likely to be involved in some fashion is the California...
By Heather Tal Murphy, Slate | 01.10.2023
Around 4 a.m. on Nov. 13, a masked man broke into a house about a mile from the University of Idaho campus and stabbed four students. Then he walked past a stunned, surviving roommate and left. By the time police...
By Nell Greenfieldboyce, NPR | 12.23.2022
When Kathleen Aukstikalnis was expecting her first baby, she turned to a common prenatal test that a lot of her friends had gotten done during their pregnancies.
The simple blood test looks at DNA that's floating freely in a pregnant...